Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Rhabdoid Tumor × Panobinostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 6 Recurrence 4 Myelodysplastic Syndromes 4 Lymphoma, Non-Hodgkin 4 Leukemia, Myeloid, Acute 4 Breast Neoplasms 4 Prostatic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 3 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Glioma 2 Diffuse Intrinsic Pontine Glioma 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Blast Crisis 2 Thrombocytosis 1 Stomach Neoplasms 1 Somatostatinoma 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sezary Syndrome 1 Rhabdoid Tumor 1

Interventions

Topotecan 2 Ifosfamide 2 sargramostim 1 etoposide phosphate 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Thiotepa 1 Stem Cell Transplantation 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Radiosurgery 1 Panobinostat 1 Microarray Analysis 1 Mesna 1 Melphalan 1 Immunohistochemistry 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Dexamethasone 1 Dasatinib 1 Cyclophosphamide 1 Carboplatin 1 Calcium Dobesilate 1 Busulfan 1 Blotting, Western 1 3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04897880 2025-02-24

NORTH

Australian & New Zealand Children's Haematology/Oncology Group

Phase 2 Terminated

Brain Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡